Organ support & nutrition

Regional citrate anticoagulation versus systemic heparin anticoagulation for continuous kidney replacement therapy in intensive care

J Crit CarePublished Interrupted time-series analysis with micro-costing study

Main finding · 90-day mortalityResult — go to the resultAdjusted odds ratio 0.98 95% CI 0.89–1.08

Authors' conclusion

Transition to RCA was associated with significant increases in healthcare resource use, without corresponding clinical benefit, and is highly unlikely to be cost-effective over a one-year time horizon.

Study context

Population
Adults receiving continuous kidney replacement therapy (CKRT) in general intensive care units (ICUs) in England and Wales, 2009–2017
Participants
69,001 adults · 181 ICUs
Exposure
ICU transition to regional citrate anticoagulation (RCA) vs systemic heparin anticoagulation (SHA) for CKRT
  • RCAn = 8,585
  • SHAn = 60,416reference
Outcome
Mortality
Follow-up
90 days
Methodological detailslinked routinely collected health records, national survey of ICUs, health economic evaluation, multicentre
  • Linked routinely collected health records
  • National survey of ICUs
  • Health economic evaluation
  • Multicentre

Main finding

90-day mortality

Adjusted odds ratio

0.98

95% CI 0.89–1.08

RCA vs SHA
aOR 0.98 (95% CI 0.89–1.08)

As reported in the abstract

Observational data: associations, not effects.

Further findings

OutcomeStep-increase (days) (95% CI)
Duration of kidney supportAfter transition to RCA · interrupted time-series analysis0.53 (0.28–0.79)
Advanced cardiovascular supportAfter transition to RCA · interrupted time-series analysis0.23 (0.09–0.38)
ICU LOSAfter transition to RCA · interrupted time-series analysis0.86 (0.24–1.49)

Incremental net monetary benefit per patient · one year

Estimated incremental net monetary benefit per patient
£ - 2376 (95% CI £ - 3841-£ - 911)
Estimated likelihood of cost-effectiveness
<0.1%

Original publication

Regional citrate anticoagulation versus systemic heparin anticoagulation for continuous kidney replacement therapy in intensive care. J Crit Care. Published 7 December 2022. doi:10.1016/j.jcrc.2022.154218

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.